Preoperative hyperglycemia is associated with adverse postoperative outcomes among patients who undergo surgery. Whether preoperative hemoglobin A 1c (HbA 1c ) or postoperative glucose levels are more useful in predicting adverse events following surgery is uncertain in the current literature.
P erioperative hyperglycemia is common among surgical patients and has been associated with adverse outcomes. 1 Chronic hyperglycemia causes hemoglobin glycation and can be measured by hemoglobin A 1c (HbA 1c ), which reflects the mean glucose level for the previous 120 days. 2 The American Diabetic Association uses HbA 1c levels of 5.7% to 6.4% and more than 6.5% for diagnosing prediabetes and diabetes, respectively. 3 Patients with elevated HbA 1c experienced more postoperative infections and longer hospital stays. 4, 5 Hemoglobin A 1c can also be used to identify patients who are at an increased risk for developing acute postoperative hyperglycemia, 6 which has also been linked to postoperative complications, including surgical site infections, an increased length of hospital stay, and mortality.
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The current literature lacks consensus on whether preoperative HbA 1c or postoperative hyperglycemia is more useful for predicting adverse events following surgery. 12, [15] [16] [17] In addition, much of the literature pertains to cardiac surgery, which represents a unique patient population that may not be generalizable to patients undergoing gastrointestinal surgery who are at a higher risk for developing postoperative infections. Finally, to our knowledge, while the relationship between perioperative hyperglycemia and postoperative complications has been examined, the effect of this relationship on readmission is largely unknown. We examined the use of preoperative HbA 1c and early postoperative glucose levels for predicting postoperative complications and readmission. We hypothesized that postoperative glucose level measurements in patients with elevated preoperative HbA 1c are more vigilantly monitored with a lower threshold of hyperglycemia for insulin treatment. We thereby assessed postoperative glucose level surveillance and insulin treatment among patients with different ranges of preoperative HbA 1c . We hypothesized that elevated early postoperative glucose levels would have greater use than preoperative HbA 1c for predicting complications and increased readmissions.
Methods
We conducted a secondary analysis of the Veteran Affairs Surgical Quality Improvement Program (VASQIP) database to perform a retrospective observational study of the relationship between preoperative HbA 1c , perioperative glucose levels, postoperative complications, and 30-day readmissions. The study protocol was reviewed and approved by the VA Central institutional review board with a waiver of informed consent granted. The Strengthening of Observational Study Designs in Epidemiology checklist was followed.
Study Population
The study population includes a subset of patients who were experiencing inpatient digestive surgeries (principal Current Procedural Terminology codes 40000-49999) at a Veterans Healthcare Administration hospital between October 1, 2007, and September 31, 2014, and who were assessed by VASQIP. Initially, 350 593 unique hospital stays involving a VASQIPassessed surgery were identified by VASQIP. Eligible surgeries were limited to digestive surgeries only by their principal Current Procedural Terminology code (40000-49999). Patients were excluded from the analysis if they had experienced a documented preoperative infection or infectious complication during the 96 hours immediately following their operation. Patients were also excluded from the analysis if they were missing a postoperative glucose level assessment or preoperative HbA 1c assessment. The final analytic sample included 23 094 unique hospital stays involving at least 1 VASQIPassessed surgical procedure ( Figure 1) . The unit of analysis for this study was the index surgical procedure. If a patient had undergone more than 1 digestive surgery during a hospitalization, only the procedural characteristics of the first surgery were included in the analysis.
Data Sources
The covariates of interest included in this analysis were collected from the VASQIP, the VA Decision Support System (DSS), and the VA Corporate Data Warehouse Inpatient data domains. Preoperative, operative, and postoperative characteristics were obtained from VASQIP. The VA Surgical Quality Improvement Program collects these characteristics via a trained nurse abstractor, thus ensuring the reliability of the variables collected.
18 Inpatient administrations of insulin in the postoperative period were identified within the DSS pharmacy data. Insulin use in the postoperative period was defined as any administration of insulin during the 48 hours following an operation.
Variables
The Meaning Increased glycemic monitoring and the early treatment of hyperglycemia to maintain peak blood glucose levels of less than 250 mg/dL during the early postoperative period may minimize a patient's risk of developing complications and being readmitted after undergoing gastrointestinal surgery.
dL, respectively. The peak glucose level was also collected as a continuous variable and examined as a 4-category variable for ease of interpretation (<120, 120-179, 180-250, and >250) after carefully examining trends between glucose as a continuous variable and each of the outcomes examined. In addition to the glucose result, the frequency of glucose level checks was also calculated as the total number of all completed glucose results during the 48 hours following an operation. We limited the postoperative setting to 48 hours to minimize the effect of postoperative events on our outcomes. The covariates of age, sex, body mass index (BMI) (calculated as weight in kilograms divided by height in meters squared), American Society of Anesthesiologists (ASA) classification, preoperative HbA 1c , preoperative glucose level, peak postoperative glucose level, emergency case status, and postoperative length of stay were selected a priori because they are significant predictors for and markers of readmission.
19 All variables, with the exception of race/ethnicity and ASA classification, were complete. While ASA classification was only missing for 4 patients (0.02%), race/ethnicity was missing for 3016 patients (14.8%). Race/ethnicity was not a statistically significant predictor of any of the outcomes and thus an unlikely confounder. Notably, when race/ethnicity was tested we found no evidence of collinearity between preoperative diabetes, postoperative blood glucose, and postoperative insulin use. Furthermore, there was no change in the interpretation of results when the variables were removed from the models.
The main outcome of interest was postdischarge readmission or the development of an infection-related postoperative complication as identified by VASQIP. While postoperative infections (a wound infection, pneumonia, urinary tract infecgtion, or sepsis) are not mutually exclusive, they were counted only once in the overall postoperative complications variable. We excluded all patients with a known infection preoperatively and for 96 hours postoperatively to minimize the likelihood that hyperglycemia during the first 48 hours reflected an ongoing infection. Inpatient readmissions in the 30 days following a hospital discharge were identified using the Corporate Data Warehouse Inpatient data domain.
Statistical Analysis
Univariate and bivariate statistics were used to examine the population and compare patients in terms of diabetes status. Univariate and bivariate differences in postoperative outcomes were examined by HbA 1c categories, glucose categories, and insulin use. In unadjusted analyses, χ 2 tests or KruskalWallis tests were used to test for differences across the groups. Smoothed plots were developed to examine changes in event rates across preoperative HbA 1c values. Logistic models adjusting for clinically relevant preoperative and operative characteristics were used to calculate the odds of each outcome across categories of preoperative HbA 1c and postoperative glucose. Preoperative HbA 1c was added to the adjusted peak 48-hour glucose levels model to understand the contribution of peak 48-hour glucose levels independently of preoperative HbA 1c . Peak 48-hour glucose levels were not included in the preoperative HbA 1c model. All analyses were completed using SAS, version 9.4 (SAS Institute). Smoothed plots were developed using the R package GGPLOT2. 20 Interaction terms were tested in the final model and included in the final model if statistically significant at P < .05.
Results

Patient and Procedural Characteristics
Patient and procedural factors stratified by a preoperative diagnosis of diabetes by VASQIP are summarized in Table 1 . The mean age for the overall cohort was 63.7 years. Most patients were men (n = 20 348, 94.5%). Patients with diabetes who were insulin-dependent had a higher BMI (32.0 vs 30.1; P < .001), included more patients with an ASA classification of 4 to 5 (19.8% vs 13.3%; P < .001), experienced more postoperative complications (29.8% vs 26.6%; P < .001), and had more 30-day readmissions (16.6% vs 14.2%; P < .001). Patients with diabetes who were insulin-dependent also had higher preoperative glucose levels (166.1 vs 133.4 mg/dL; P < .001), initial postoperative glucose levels (190.7 vs 160.0 mg/dL; P < .001), and peak 48-hour postoperative glucose levels (230.8 vs 182.0 mg/dL; P < .001). The mean HbA 1c for the cohort was 6.7%, with 7.0% among patients with diabetes who were noninsulindependent and 8.0% among patients with diabetes who were Table 3 . By contrast, elevated peak 48-hour postoperative blood glucose levels were associated with increased odds for developing postoperative complications, but these associations were only marginally significant after adjusting for other patient characteristics (Table 2) . After adjustment, only 30-day readmissions remained significantly associated with peak 48-hour postoperative glucose levels (>250 vs <120 mg/dL; OR, 1.20; 95% CI, 1.01-1.42).
The interaction of preoperative HbA 1c and postoperative glucose was of specific interest, but we failed to find a statis- To convert to millimoles per liter, multiply by 0.0555.
To convert to the proportion of total hemoglobin, multiply by 0.01. tically significant interaction between the 2 terms in the adjusted model, and it was therefore not included in the final model.
Postoperative Glucose Level Surveillance
The mean total glucose level was 4.92 for patients with an HbA 1c of less than 5.7%, 6.89 for patients with an HbA 1c ranging from 5.7% to 6.4%, and 9.71 for patients with an HbA 1c of more than 6.5% (P < .001). The frequency of hyperglycemia surveillance by means of glucose level checks increased as the preoperative HbA 1c increased from 3% to 10% (Figure 2A ).
Postoperative Hyperglycemia Treatment
Patients with preoperative HbA 1c more than 6.5% have lower thresholds for insulin use per postoperative glucose until their glucose level reaches 240 mg/dL, in which insulin use equal- izes across all preoperative HbA 1c categories ( Figure 2B ). The closest preoperative HbA 1c and glucose levels, as well as the highest 48-hour glucose levels, were the strongest predictors of receiving insulin in the 48 hours following surgery. Overall, patients with an HbA 1c ranging from 5.7% to 6.4% were not more likely to receive insulin compared with patients with an HbA 1c of less than 5.7%. However, patients with an HbA 1c of more than 6.5% were 1 to 3 times more likely to receive insulin when their postoperative glucose values were less than 250 mg/dL. Specifically, 530 patients (11.5%) with an HbA 1c of 5.7% or less received insulin compared with 1422 (17.5%) with an HbA 1c ranging from 5.7% to 6.4% and 3895 (44.2%) with an HbA 1c of more than 6.4 (P < .01). Once the postoperative glucose level reaches 250 mg/dL, all patients have an equal opportunity to receive insulin regardless of postoperative glucose levels. Other factors associated with insulin use are age, sex, BMI, ASA classification, preoperative diabetes, preoperative sepsis, and hypertensive medications.
Discussion
Patients with insulin-dependent diabetes have higher postoperative complication rates compared with patients with noninsulin-dependent diabetes and those without diabetes. 4,5 They also have higher 14-and 30-day readmission rates. Even after adjusting for diabetes, preoperative HbA 1c , insulin use, and BMI, patients with peak 48-hour postoperative blood glucose levels of more than 250 mg/dL are 20% more likely to be readmitted within 30 days. Contrary to this, patients with a preoperative HbA 1c of more than 6.5% are 17% less likely to be readmitted within 30 days. We hypothesized that because HbA 1c is known preoperatively, hyperglycemia in these patients is more vigilantly monitored and treated with insulin. Our findings indicated that the frequency of glucose level checks increased with increasing HbA 1c until HbA 1c equals 10%. In addition, the threshold to treat hyperglycemia with insulin was lower for patients with an HbA 1c of more than 6.5%. The association between postoperative hyperglycemia and infectious complications is consistent with prior findings.
8,10
We believe that postoperative hyperglycemia reflects an acute inflammatory phase and the host's response that may lead to increased postoperative complications. Kotagel et al 21 described a dose-dependent association between hyperglycemia and adverse events among patients without diabetes. The authors attributed this finding to several theories, including that patients with diabetes may be more likely to be tested and treated for hyperglycemia. Our findings suggest this theory holds true, and our study expands on this work by looking at readmissions. The current literature lacks consensus regarding the association between HbA 1c and postoperative complications that lead to readmission, 12, 22 and the finding of elevated HbA 1c as protective of postoperative complications and readmissions is novel. It has been proposed that HbA 1c is the most significant predictor of postoperative complications, partially because preoperative hyperglycemia corresponds to postoperative hyperglycemia and the ability to control it. 17 As opposed to creating separate models for preoperative and postoperative hyperglycemia, we created one model that accounted for HbA 1c , postoperative hyperglycemia, diabetes status, and insulin use and found that HbA 1c was not a significant predictor of complications and was protective of 30-day readmission. We tested whether elevated HbA 1c is protective of postoperative complications and thereby readmissions because of the increased monitoring and treatment of hyperglycemia in these patients. Only 59% of hospitalized patients undergo glucose monitoring and, of these that are found to be hyperglycemic, only 54% are treated with insulin. 23 Because the risk of postoperative complications corresponds to the 
Strengths and Limitations
Our study was limited to patients undergoing gastrointestinal surgery, among whom there are studies on the relationship of diabetes and hyperglycemia on postoperative outcomes. A strength of this study is the use of all glucose measurements and treatment in a national cohort of patients undergoing surgery to evaluate the association of perioperative glucose on complications and readmissions. However, it also has its limitations. We chose to categorize HbA 1c based on the American Diabetes Association cutoffs for normal (<5.7%), prediabetes (5.7 -6.4%), and diabetes (>6.5%). This study does not delineate the outcomes for elevated HbA 1c of more than 7%, more than 8%, or even more than 10%, in which the power is lacking. In addition, because we excluded patients who died in the hospital to examine readmissions, patients with the most severe complications resulting in in-hospital death were excluded from this study. However, since we hypothesized that postoperative hyperglycemia was associated with worse outcomes, this limitation would result in bias toward the null. While all patients underwent a procedure in the general surgery specialty, they did not undergo the same procedure. Because we did not compare the specific type of surgery and patient perioperative glucose or HbA 1c , it is possible that the results were affected. In addition, there are several potential confounders, including laparoscopic vs open procedure, indications for surgery, and antibiotic use, which were not addressed and could limit the study. We also excluded patients without preoperative HbA 1c within 90 days of undergoing surgery or a postoperative glucose level assessment, which may have introduced selection bias (eTable 1 in the Supplement). Finally, because our data source is the VA, our patient population is predominantly male and as a retrospective study, we cannot assess causation.
Conclusions
In summary, early postoperative glucose increases the risk of 30-day readmission, whereas elevated preoperative HbA 1c is associated with decreased readmission potentially because of more intensive monitoring and intervention of postoperative hyperglycemia. These findings advocate for increased glycemic monitoring in the early postoperative phase and early treatment of hyperglycemia to maintain peak blood glucose levels of less than 250 mg/dL to minimize the risk for complications because of hyperglycemia. Further study is warranted to address causation.
